160 related articles for article (PubMed ID: 3891589)
1. A highly restricted antigen for renal cell carcinoma defined by a monoclonal antibody.
Moon TD; Vessella RL; Palme DF; Nowak JA; Lange PH
Hybridoma; 1985; 4(2):163-71. PubMed ID: 3891589
[TBL] [Abstract][Full Text] [Related]
2. Monoclonal antibodies to human renal cell carcinoma: recognition of shared and restricted tissue antigens.
Vessella RL; Moon TD; Chiou RK; Nowak JA; Arfman EW; Palme DF; Peterson GA; Lange PH
Cancer Res; 1985 Dec; 45(12 Pt 1):6131-9. PubMed ID: 3904980
[TBL] [Abstract][Full Text] [Related]
3. Tumor-specific monoclonal antibodies for renal cell carcinoma.
Schärfe T; Becht E; Kaltwasser R; Thüroff JW; Jacobi GH; Hohenfellner R
Eur Urol; 1985; 11(2):117-20. PubMed ID: 2408893
[TBL] [Abstract][Full Text] [Related]
4. Mouse monoclonal antibodies with restricted specificity for human renal cell carcinoma and ability to modulate the tumor cell growth in vitro.
Tokuyama H; Tokuyama Y
Hybridoma; 1988 Apr; 7(2):155-65. PubMed ID: 3372001
[TBL] [Abstract][Full Text] [Related]
5. Monoclonal antibodies to kidney and tumor-associated surface antigens of human renal cell carcinoma.
Luner SJ; Ghose T; Chatterjee S; Cruz HN; Belitsky P
Cancer Res; 1986 Nov; 46(11):5816-20. PubMed ID: 3530441
[TBL] [Abstract][Full Text] [Related]
6. Analysis of a mouse monoclonal antibody that reacts with a specific region of the human proximal tubule and subsets renal cell carcinomas.
Bander NH; Finstad CL; Cordon-Cardo C; Ramsawak RD; Vaughan ED; Whitmore WF; Oettgen HF; Melamed MR; Old LJ
Cancer Res; 1989 Dec; 49(23):6774-80. PubMed ID: 2684399
[TBL] [Abstract][Full Text] [Related]
7. Reactivities of mouse monoclonal antibody K2.7 to renal cancers in complement dependent cytotoxicity and antibody dependent cell-mediated cytotoxicity.
Kinouchi T; Bander NH; Kotake T
J Urol; 1995 Jul; 154(1):288-92. PubMed ID: 7776448
[TBL] [Abstract][Full Text] [Related]
8. A renal cell carcinoma neoplastic antigen detectable by immunohistochemistry is defined by a murine monoclonal antibody.
Kochevar J
Cancer; 1987 Jun; 59(12):2031-6. PubMed ID: 3552200
[TBL] [Abstract][Full Text] [Related]
9. Antigenic heterogeneity of long-term cultured renal carcinoma cell line (KU-2) analyzed by tumor specific monoclonal antibodies.
Nakamura S
Keio J Med; 1986 Oct; 35(4):276-90. PubMed ID: 2438447
[No Abstract] [Full Text] [Related]
10. [Production of monoclonal antibody to renal cell carcinoma].
Terashima Y; Kanamori S; Hattori T; Kimura G; Akimoto M
Nihon Hinyokika Gakkai Zasshi; 1989 Jun; 80(6):838-46. PubMed ID: 2677465
[TBL] [Abstract][Full Text] [Related]
11. Monoclonal antibodies in human renal cell carcinoma and their use in radioimmune localization and therapy of tumor xenografts.
Lange PH; Vessella RL; Chiou RK; Elson MK; Moon TD; Palme D; Shafer RK
Surgery; 1985 Aug; 98(2):143-50. PubMed ID: 4023915
[TBL] [Abstract][Full Text] [Related]
12. [Renal cancer specific antitumor activities of a mouse monoclonal antibody K2.7 to human renal cell carcinoma].
Kinouchi T; Kotake T
Hinyokika Kiyo; 1992 Nov; 38(11):1325-31. PubMed ID: 1485589
[TBL] [Abstract][Full Text] [Related]
13. HER-2/neu is expressed in human renal cell carcinoma at heterogeneous levels independently of tumor grading and staging and can be recognized by HLA-A2.1-restricted cytotoxic T lymphocytes.
Seliger B; Rongcun Y; Atkins D; Hammers S; Huber C; Störkel S; Kiessling R
Int J Cancer; 2000 Aug; 87(3):349-59. PubMed ID: 10897039
[TBL] [Abstract][Full Text] [Related]
14. Heteroconjugate antibody-directed killing of autologous human renal carcinoma cells by in vitro-activated lymphocytes.
Kerr L; Huntoon C; Donohue J; Leibson PJ; Bander NH; Ghose T; Luner SJ; Vessella R; McKean DJ
J Immunol; 1990 May; 144(10):4060-7. PubMed ID: 2139677
[TBL] [Abstract][Full Text] [Related]
15. Superior antitumor in vitro responses of allogeneic matched sibling compared with autologous patient CD8+ T cells.
Kausche S; Wehler T; Schnürer E; Lennerz V; Brenner W; Melchior S; Gröne M; Nonn M; Strand S; Meyer R; Ranieri E; Huber C; Falk CS; Herr W
Cancer Res; 2006 Dec; 66(23):11447-54. PubMed ID: 17145892
[TBL] [Abstract][Full Text] [Related]
16. In vitro production of human antibodies against bladder cancer: characterization and diagnostic implications.
Pizza G; De Vinci C
J Exp Pathol; 1987; 3(4):335-46. PubMed ID: 2457663
[No Abstract] [Full Text] [Related]
17. Internal image anti-idiotype antibodies related to renal-cell carcinoma-associated antigen G250.
Uemura H; Okajima E; Debruyne FM; Oosterwijk E
Int J Cancer; 1994 Feb; 56(4):609-14. PubMed ID: 7509324
[TBL] [Abstract][Full Text] [Related]
18. Monoclonal antibody identification and characterization of a Mr 43,000 membrane glycoprotein associated with human breast cancer.
Edwards DP; Grzyb KT; Dressler LG; Mansel RE; Zava DT; Sledge GW; McGuire WL
Cancer Res; 1986 Mar; 46(3):1306-17. PubMed ID: 3510721
[TBL] [Abstract][Full Text] [Related]
19. Immunocytochemical reactivity of a mouse monoclonal antibody CDI 315B raised against human breast carcinoma.
Beketić-Oresković L; Sarcević B; Malenica B; Novak D
Neoplasma; 1993; 40(2):69-74. PubMed ID: 8394515
[TBL] [Abstract][Full Text] [Related]
20. Development and characterization of anti-renal cell carcinoma x antichelate bispecific monoclonal antibodies for two-phase targeting of renal cell carcinoma.
Kranenborg MH; Boerman OC; Oosterwijk-Wakka JC; de Weijert MC; Corstens FH; Oosterwijk E
Cancer Res; 1995 Dec; 55(23 Suppl):5864s-5867s. PubMed ID: 7493361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
